StockComparison Logo
vs

MLTX vs SCL

Comparison between MoonLake Immunotherapeutics - Class A (MLTX, Company) and Stepan Company (SCL, Company).

MLTX is from the Healthcare sector, while SCL is from the Basic Materials sector.

5-Year PerformanceMLTX has outperformed SCL, delivering a return of +14.1% compared to -11.5%

MLTX vs SCL - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
MLTX
$1.35B
SCL
$1.35B
Max Drawdown
MLTX
90.22%
Winner
SCL
69.33%
Sharpe Ratio
Winner
MLTX
0.52
SCL
0.19
5Y Beta
Winner
MLTX
0.95
SCL
0.98
Industry
MLTX
Biotechnology
SCL
Specialty Chemicals
P/E Ratio
Winner
MLTX
-5.29
SCL
2590.93
Forward P/E
MLTX
N/A
SCL
22.62
PEG Ratio
Winner
MLTX
-0.03
SCL
1.75
Dividend Yield
MLTX
N/A
SCL
2.66%
5Y Dividends CAGR
MLTX
N/A
SCL
5.70%
5Y EPS CAGR
MLTX
N/A
SCL
-65.69%
Debt to Equity
Winner
MLTX
38.98%
SCL
54.63%
Free Cash Flow Yield
MLTX
-16.60%
Winner
SCL
2.76%
P/S Ratio
MLTX
N/A
SCL
0.57
P/B Ratio
MLTX
6.60
Winner
SCL
1.12

MLTX vs SCL - Historical Returns

Returns include dividend reinvestment.

1M
MLTX
-8.77%
Winner
SCL
+9.19%
3M
Winner
MLTX
+14.35%
SCL
+12.10%
6M
Winner
MLTX
+22.07%
SCL
+4.50%
1Y
MLTX
-65.27%
Winner
SCL
+2.87%
5Y(CAGR)
Winner
MLTX
+14.13%
SCL
-11.53%
10Y(CAGR)
MLTX
N/A
SCL
+0.36%
Max(CAGR)
Winner
MLTX
+11.24%
SCL
+8.36%

MLTX vs SCL - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearMLTXSCL
2026+62.01%+24.02%
2025-75.40%-22.75%
2024-9.07%-29.48%
2023+447.76%-7.75%
2022+5.85%-12.77%
2021-8.76%+3.69%
2020+8.39%+15.69%
2019N/A+39.84%
2018N/A-6.20%
2017N/A-1.14%
2016N/A+73.31%
2015N/A+26.22%
2014N/A-37.62%
2013N/A+18.33%
2012N/A+41.78%
2011N/A+5.32%
2010N/A+15.49%
2009N/A+41.39%
2008N/A+53.01%
2007N/A+7.15%
2006N/A+18.77%
2005N/A+15.55%
2004N/A-2.23%
2003N/A+5.01%
2002N/A+2.45%
2001N/A+11.91%
2000N/A+5.75%
1999N/A-1.43%

MLTX vs SCL Drawdown Comparison

The maximum drawdown for MLTX was -90.22%, occurring on Sep 29, 2025. This drawdown has not yet recovered.

The maximum drawdown for SCL was -66.77%, occurring on Nov 4, 2025. This drawdown has not yet recovered.

The current MLTX drawdown is -69.68%. The current SCL drawdown is -53.67%.

RankMLTXSCL
#1-90.22%
Feb 12, 2024 - Sep 29, 2025
-66.77%
May 6, 2021 - Nov 4, 2025
#2-64.60%
Apr 5, 2022 - Feb 7, 2023
-60.98%
Aug 14, 2008 - Sep 10, 2009
#3-41.80%
Oct 5, 2023 - Dec 27, 2023
-43.86%
Dec 23, 2013 - Jul 21, 2016
#4-25.65%
Feb 18, 2021 - Apr 5, 2022
-32.15%
Jan 13, 2020 - Jul 23, 2020
#5-19.79%
Mar 8, 2023 - Apr 24, 2023
-31.96%
Jul 13, 2001 - Mar 8, 2002
#6-18.38%
Jul 28, 2023 - Oct 5, 2023
-30.85%
Apr 29, 2010 - Jul 27, 2011
#7-15.06%
Dec 27, 2023 - Feb 9, 2024
-30.20%
Jan 13, 2010 - Apr 20, 2010
#8-14.12%
Apr 24, 2023 - May 4, 2023
-25.43%
Jul 5, 2000 - Jan 18, 2001
#9-12.27%
Jun 9, 2023 - Jun 26, 2023
-25.18%
Aug 7, 2002 - Sep 6, 2005
#10-7.95%
Jul 19, 2023 - Jul 26, 2023
-24.63%
Jul 25, 2017 - Feb 13, 2019
#11-7.48%
Jul 5, 2023 - Jul 14, 2023
-21.41%
Jul 10, 2006 - Jul 19, 2007
#12-5.83%
Oct 22, 2020 - Dec 1, 2020
-18.09%
Dec 9, 2016 - Apr 25, 2017
#13-5.45%
May 10, 2023 - May 25, 2023
-18.01%
Mar 15, 2013 - Dec 6, 2013
#14-5.45%
Dec 31, 2020 - Jan 8, 2021
-17.97%
Dec 24, 2007 - Feb 27, 2008
#15-4.78%
Jan 8, 2021 - Feb 11, 2021
-17.96%
Jul 28, 2011 - Oct 27, 2011

Correlation

Correlation between MLTX and SCL is -0.41 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.41
-101

Select Stocks to Compare